Inhaled Isopropyl Alcohol for Treatment of Nausea
Recruiting
Phase 2
Phase 3
Interventional Study
Vomiting
Nausea
Children, Only
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 7 – 17
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 84 (estimated)
- Sponsor
- State University of New York at Buffalo · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with a chief complaint of nausea or vomiting
* Ages 7-178 years, both sexes
* Weight ≥ 15 kg
* Baxter Animated Retching Faces (BARF) nausea severity score ≥ 4/10
Exclusion Criteria:
* 1\. Require IV access
* Inability to breathe in/out through the nose
* Anosmia (se…
Contacts